Incidence of deferasirox-associated renal tubular dysfunction in children and young adults with beta-thalassaemia-Reference-Cited by-同舟云学术

Incidence of deferasirox-associated renal tubular dysfunction in children and young adults with beta-thalassaemia

Published:2014-07-02 Issue:3 Volume:167 Page:434-436
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Dee Cathleen Michelle A.¹,Cheuk Daniel Ka Leung¹,Ha Shau-Yin¹,Chiang Alan Kwok-Shing¹,Chan Godfrey Chi-Fung¹

Affiliation:

1. Department of Paediatrics & Adolescent Medicine; Li Ka Shing Faculty of Medicine; Queen Mary Hospital; The University of Hong Kong; Hong Kong China

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.13002/fullpdf

Reference7 articles.

1. Blood Chemistries and Body Fluids

2. Iron chelation with deferasirox in adult and pediatric patients with thalassemia major: efficacy and safety during 5 years' follow-up;Cappellini;Blood,2011

3. Consequences and costs of noncompliance with iron chelation therapy in patients with transfusion-dependent thalassemia: a literature review;Delea;Transfusion,2007

4. Acute renal failure and Fanconi syndrome due to deferasirox;Grangé;Nephrology, Dialysis, Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association,2010

5. Serum creatinine as a marker of muscle mass in chronic kidney disease: results of a cross-sectional study and review of literature;Patel;Journal of Cachexia, Sarcopenia and Muscle,2013

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnosis, treatment, and surveillance of Diamond-Blackfan anaemia syndrome: international consensus statement;The Lancet Haematology;2024-05

2. Drug Selection and Posology, Optimal Therapies and Risk/Benefit Assessment in Medicine: The Paradigm of Iron-Chelating Drugs;International Journal of Molecular Sciences;2023-11-25

3. Biochemical Markers of Early Renal Dysfunction in Patients with β-thalassemia Major: A Systematic Review and Meta-analysis;Current Medicinal Chemistry;2023-10-26

4. The Effect of Deferasirox Dose and Treatment Duration on Frequency of Proteinuria and Renal Functions in Patients with Thalassemia Major;Cyprus Journal of Medical Sciences;2023-01-01

5. Stable Luminescent Poly(Allylaminehydrochloride)-Templated Copper Nanoclusters for Selectively Turn-Off Sensing of Deferasirox in β-Thalassemia Plasma;Pharmaceuticals;2021-12-16